During the past decade, Mayo Clinic, Clinical Studies Unit conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mayo Clinic, Clinical Studies Unit" are "Aortoiliac Aneurysms" (2 trials), "Iliac Aneurysms" (2 trials), "CDI" (1 trials), "Clostridium Difficile" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "Mayo Clinic, Clinical Studies Unit" in a lesser frequency.

Most popular intervention types in "Mayo Clinic, Clinical Studies Unit" are "Device" (2 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Zenith® Branch Endovascular Graft-Iliac Bifurcation," (2 trials), "Atrium iCAST™" (1 trials), "Macitentan" (1 trials) and "VE303" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mayo Clinic, Clinical Studies Unit" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Mayo Clinic, Clinical Studies Unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mayo Clinic, Clinical Studies Unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mayo Clinic, Clinical Studies Unit, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".